Clinical And Biochemical Outcomes Of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors In Type 2 Diabetes Mellitus Patients

Background: SGLT-2 inhibitors are a group of oral medications that work independently of insulin working as anti-diabetics by enhancing the excretion of glucose. The purpose of our study was to assess the improvement in terms of HbA1c, weight, blood pressure and BMI and the hepatics and renal effect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the Endocrine Society 2021-05, Vol.5 (Supplement_1), p.A467-A467
Hauptverfasser:	Saleem, Muhammad, Ram, Nanik, Khan, Sajjad Ali, Suchal, Zafar Aleem, Mehdi Khan, Muhammad Mustansir
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Mellitus and Glucose Metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!